From: Breast cancer-specific survival by molecular subtype in different age groups of women in Scotland
Subtype | Â | Unadjusted HR (95% CI) P value | Adjusted HR (95% CI) P value | ||
---|---|---|---|---|---|
 | Deaths/cases* | < 50 years | 70 years or older | < 50 years | 70 years or older |
ER+ | 5,238/42,146 | 1.43 (1.33–1.53) | 2.35 (2.21–2.50) | 0.89 (0.82–0.96) | 1.34 (1.24–1.45) |
ER- | 2,378/9,105 | 1.07 (0.96–1.18) | 2.09 (1.90–2.29) | 0.92 (0.83–1.02) | 1.30 (1.16–1.46) |
Luminal A | 723/13,755 | 1.42 (1.11–1.81) | 4.60 (3.91–5.42) | 0.66 (0.51–0.86) | 1.49 (1.23–1.80) |
Luminal B | 753/7,132 | 1.21 (1.01–1.46) | 2.62 (2.22–3.09) | 1.10 (0.90–1.34) | 1.39 (1.14–1.69) |
HER2-expressed | 147/1,034 | 0.88 (0.55–1.42) | 2.86 (2.01–4.09) | 0.64 (0.39–1.06) | 0.72 (0.45–1.16) |
TNBC | 453/2,519 | 1.24 (0.98–1.56) | 2.32 (1.87–2.88) | 1.07 (0.84–1.37) | 1.49 (1.15–1.94) |